Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_assertion type Assertion NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_head.
- NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_assertion description "[The present study was designed to assess the contribution of these SNPs to disease progression in patients with chronic hepatitis C. The study enrolled 220 Japanese patients with chronic hepatitis C. Three SNPs, -1195 COX-2, PNPLA3 and IL28B (rs8099917), were genotyped in order to analyze their association with hepatic fibrosis and inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_provenance.
- NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_assertion evidence source_evidence_literature NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_provenance.
- NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_assertion SIO_000772 22863264 NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_provenance.
- NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_assertion wasDerivedFrom befree-2016 NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_provenance.
- NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_assertion wasGeneratedBy ECO_0000203 NP1002729.RAcTJ439kZKqMU8ooquXbsmbGsU7VHg6GA5d_SCOViMpk130_provenance.